脳神経外科学
Neurosurgery
整理番号	論文の種類	著者名	論文タイトル	誌名、書名等	巻号ページ	年	doi
2247001	原著	Hisamitsu Y, Kubo T, Fudaba H, Sugita K, Fujiki M, Ide S, Kiyosue H, Hori Y.	High D-Dimer Concentration Is a Significant Independent Prognostic Factor in Patients with Acute Large Vessel Occlusion Undergoing Endovascular Thrombectomy.	World Neurosurg.	160:e487-e493.	2022	10.1016/j.wneu.2022.01.052.
2247002	原著	Iuchi T, Inoue A, Hirose Y, Morioka M, Horiguchi K, Natsume A, Arakawa Y, Iwasaki K, Fujiki M, Kumabe T, Sakata Y.	Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan.	Neurooncol Adv.	12;4(1):vdab189.	2022	10.1093/noajnl/vdab189.
2247003	原著	Fujiki M, Matsushita W, Kawasaki Y, Fudaba H.	Monophasic-Quadripulse Theta Burst Magnetic Stimulation for Motor Palsy Functional Evaluation After Intracerebral Hemorrhage.	Front Integr Neurosci.	11;16:827518.	2022	10.3389/fnint.2022.827518.
2247004	症例報告	Aso D, Fudaba H, Hisamitsu Y, Kubo T, Fujiki M.	Mycotic pseudoaneurysm in the internal carotid artery secondary to cranial base abscess diagnosed with optic neuritis: a case report.	Br J Neurosurg.	24:1-4.	2022	10.1080/02688697.2022.2090503.
2247005	原著	Kuga K, Ozaki H, Fujiki M.	Motor-evoked potentials after focal electrical stimulation predict drug-induced convulsion potentials in rats.	Toxicol Mech Methods.	22:1-8.	2022	10.1080/15376516.2022.2101038.
2247006	原著	Matsuta H, Shimomura T, Kouchiyama T, Fujiki M.	Continuous theta-burst stimulation to the sensorimotor cortex affects contralateral gamma-aminobutyric acid level and resting-state networks.	PLoS One.	15;17(8):e0272268.	2022	doi:10.1371/journal.pone.0272268.
2247007	Proceedings	Anan M. Takao K, Matsuhita W, Aso D, Fudaba H, Onishi K, Matsuta H, Sugita K, Matsuda T, Kubo T, Nagai Y, Fujiki M	Lactate and lactate dehydrogenase in carotid cistern as biomarkers of early brain injury and delayed cerebral ischemia of aneurysmal subarachnoid hemorrhage	J Stroke	https://j-stroke.org/articles/file/KJJSC2022_Abstracts_0917_0918.pdf	2022
2247008	原著	Higa N, Akahane T, Yokoyama S,  Yonezawa H, Uchida H, Takajo T, Otsuji R, Hamada T, Matsuo K, Kirishima M, Hata H, Hanaya R, Tanimoto A, Yoshimoto K	Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma.	Neurooncol Adv.	4(1), 1–9: vdac097.	2022	10.1093/noajnl/vdac097
2247009	原著	Funakoshi Y, Takigawa K, Hata N, Kuga D, Hatae R, Sangatsuda Y, Fujioka Y, Otsuji R, Sako A, Yoshitake T, Togao O, Hiwatashi A, Iwaki T, Mizoguchi M, Yoshimoto K.	Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study.	World Neurosurg.	159:e479-e487.	2022	10.1016/j.wneu.2021.12.075.
2247010	原著	Natsume A, Arakawa Y, Narita Y, Sugiyama K, Hata N, Muragaki Y, Shinojima N, Kumabe T, Saito R, Motomura K, Mineharu Y, Miyakita Y, Yamasaki F, Matsushita Y, Ichimura K, Ito K, Tachibana M, Kakurai Y, Okamoto N, Asahi T, Nishijima S, Yamaguchi T, Tsubouchi H, Nakamura H, Nishikawa R.	The first-in-human phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas.	Neuro Oncol.	Jun 20:noac155. doi:  Epub ahead of	2022	10.1093/neuonc/noac155.
2247011	原著	Higa N, Akahane T, Yokoyama S, Yonezawa H, Uchida H, Fujio S, Kirishima M, Takigawa K, Hata N, Toh K, Yamamoto J, Hanaya R, Tanimoto A, Yoshimoto K.	Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel.	Neurol Med Chir.	62(9):391-399.	2022	10.2176/jns-nmc.2022-0103.
2247012	症例報告	Fujii Y, Hatae R, Hata N, Suzuki SO, Sangatsuda Y, Takigawa K, Funakoshi Y, Fujioka Y, Kuga D, Mizoguchi M, Iwaki T, Yoshimoto K.	A case of ganglioglioma grade 3 with H3 K27M mutation arising in the medial temporal lobe in an elderly patient.	Neuropathology.	42(3):197-203.	2022	10.1111/neup.12793
2247013	著書	藤木　稔	局所性脳損傷とびまん性脳損傷	今日の治療指針2023	50-51	2022
2247014	原著	Mishima K, Nishikawa R, Narita Y, Mizusawa J, Sumi M, Koga T, Sasaki N, Kinoshita M, Nagane M, Arakawa Y, Yoshimoto K, Shibahara I, Shinojima N, Asano K, Tsurubuchi T, Sasaki H, Asai A, Sasayama T, Momii Y, Sasaki A, Nakamura S, Kojima M, Tamaru J, Tsuchiya K, Gomyo M, Abe K, Natsumeda M, Yamasaki F, Katayama H, Fukuda H.	Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.	Neuro Oncol.	Nov 5:noac246.	2022	doi:10.1093/neuonc/noac246.